May 17, 2023 Gynecology Hormone therapy should be offered to more women with severe menopause: review
April 28, 2023 Clinical Research FDA approves new pill developed to reduce the risk of re-infections by repopulating microbiome after patients complete antibiotic treatment for C. difficile
April 25, 2023 Generic Drugs FDA data shows that mifepristone safety-use profile is better than some common, low-risk prescription drugs including penicillin and Viagra. Some U.S. judicial rulings claiming the contrary are not supported by the evidence.
April 24, 2023 Infectious Disease Health Canada approves new antibody drug to help prevent serious RSV in babies
March 31, 2023 Endocrinology Gender dysphoria in young people is rising—and so is professional disagreement
March 27, 2023 Cancer/Oncology Prostate cancer: New combination therapy could reduce progression risk
February 2, 2023 General information The last drug that can fight gonorrhea is starting to falter. Report from Massachusetts Department of Health uncovers new resistant strains to multiple antibiotic regimens.
February 1, 2023 Prescription Drugs Health Canada rightly conducts safety review on off-label prescribing of breastfeeding drug, domperidone, amid psychiatric concerns as well as risk of cardiac arrhythmia. Available in US as investigational drug but banned for general use.
January 30, 2023 Health Policy Health Canada sticks with Evusheld despite U.S. FDA dropping the COVID drug
January 19, 2023 Allergy/Immunology Quebec man with debilitating skin condition needs some compassion from the Quebec Government to cover the cost of the medication (that is working) whether or not it was vaccine-related to help him resume a normal life. But they do not seem to care.